Enhanced auditory neuron survival following cell-based bdnf treatment in the deaf guinea pig

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Pettingill, Lisa N ^a   Wise, Andrew K ^a,b   Geaney, Marilyn S ^c   Shepherd, Robert K ^a,b  

^a BIONIC EAR INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Living Cell Technologies Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCURONIC ACID; HEXURONIC ACID;

ACOUSTIC NERVE FIBER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENCAPSULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; EX VIVO GENE TRANSFER; EXPERIMENTAL GUINEA PIG; FEMALE; GENE OVEREXPRESSION; HEARING IMPAIRMENT; IN VIVO STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; RAT; SCHWANN CELL; THERAPY EFFECT; TREATMENT DURATION; ANIMAL; COCHLEAR NERVE; DRUG EFFECT; GENETIC TRANSFECTION; GUINEA PIG; IMPLANTATION; MICROCAPSULE; NERVE CELL; PATHOLOGY; TRANSPLANTATION;

CAVIA;

ALGINATES; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAPSULES; CELL SURVIVAL; COCHLEAR IMPLANTATION; COCHLEAR NERVE; DEAFNESS; GLUCURONIC ACID; GUINEA PIGS; HEXURONIC ACIDS; NEURONS; RATS; SCHWANN CELLS; TRANSFECTION;

EID: 79954506101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018733     Document Type: Article

References (65)

1. Ernfors P, Merlio JP, Persson H, (1992) Cells Expressing mRNA for Neurotrophins and their Receptors During Embryonic Rat Development. Eur J Neurosci 4: 1140-1158.
2. Pirvola U, Arumae U, Moshnyakov M, Palgi J, Saarma M, et al. (1994) Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 75: 131-144.
3. Schecterson LC, Bothwell M, (1994) Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear. Hear Res 73: 92-100.
4. Ylikoski J, Pirvola U, Moshnyakov M, Palgi J, Arumae U, et al. (1993) Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res 65: 69-78.
5. Tan J, Shepherd RK, (2006) Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling. Am J Pathol 169: 528-543.
6. Stankovic K, Rio C, Xia A, Sugawara M, Adams JC, et al. (2004) Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J Neurosci 24: 8651-8661.
7. Ernfors P, Duan ML, ElShamy WM, Canlon B, (1996) Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2: 463-467.
8. Gillespie LN, Clark GM, Bartlett PF, Marzella PL, (2003) BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to an accelerated loss of survival effects. J Neurosci Res 71: 785-790.
9. Gillespie LN, Clark GM, Marzella PL, (2004) Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 15: 1121-1125.
10. Lalwani AK, Han JJ, Castelein CM, Carvalho GJ, Mhatre AN, (2002) In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 112: 1325-1334.
11. McGuinness SL, Shepherd RK, (2005) Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol Neurotol 23: 1064-1072.
12. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, et al. (1997) Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15: 631-643.
13. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y, (2004) Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9: 135-143.
14. Noushi F, Richardson RT, Hardman J, Clark G, O'Leary S, (2005) Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol Neurotol 26: 528-533.
15. Richardson RT, O'Leary S, Wise A, Hardman J, Clark G, (2005) A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear Res 204: 37-47.
16. Richardson RT, Wise AK, Thompson BC, Flynn BO, Atkinson PJ, et al. (2009) Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30: 2614-2624.
17. Shepherd RK, Coco A, Epp SB, Crook JM, (2005) Chronic depolarisation enhances the trophic effects of BDNF in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 486: 145-158.
18. Staecker H, Gabaizadeh R, Federoff H, Van De Water TR, (1998) Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 119: 7-13.
19. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR, (1996) NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 7: 889-894.
20. Wise AK, Hume CR, Flynn BO, Jeelall YS, Suhr CL, et al. (2010) Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18: 1111-1122.
21. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, et al. (2000) Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 1: 315-325.
22. Wise AK, Richardson R, Hardman J, Clark G, O'Leary S, (2005) Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487: 147-165.
23. Kanzaki S, Stover T, Kawamoto K, Prieskorn DM, Altschuler RA, et al. (2002) Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 454: 350-360.
24. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, et al. (2002) Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 99: 1657-1660.
25. Yamagata T, Miller JM, Ulfendahl M, Olivius NP, Altschuler RA, et al. (2004) Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J Neurosci Res 78: 75-86.
26. Chikar JA, Colesa DJ, Swiderski DL, Di Polo A, Raphael Y, et al. (2008) Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res 245: 24-34.
27. Pettingill LN, Richardson RT, Wise AK, O'Leary SJ, Shepherd RK, (2007) Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system. IEEE Trans Biomed Eng 54: 1138-1148.
28. Shepherd RK, Coco A, Epp SB, (2008) Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res 242: 100-109.
29. Montero CN, Hefti F, (1988) Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci 8: 2986-2999.
30. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ, (1994) Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A 91: 1632-1636.
31. Agterberg MJ, Versnel H, van Dijk LM, de Groot JC, Klis SF, (2009) Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J Assoc Res Otolaryngol 10: 355-367.
32. Blesch A, Tuszynski MH, (2003) Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol 467: 403-417.
33. Tobias CA, Han SS, Shumsky JS, Kim D, Tumolo M, et al. (2005) Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J Neurotrauma 22: 138-156.
34. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, et al. (2007) Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228: 180-187.
35. Hu Y, Leaver SG, Plant GW, Hendriks WT, Niclou SP, et al. (2005) Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol Ther 11: 906-915.
36. Girard C, Bemelmans AP, Dufour N, Mallet J, Bachelin C, et al. (2005) Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 25: 7924-7933.
37. Golden KL, Pearse DD, Blits B, Garg MS, Oudega M, et al. (2007) Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol 207: 203-217.
38. Pettingill LN, Minter RL, Shepherd RK, (2008) Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 152: 821-828.
39. Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, et al. (2005) Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 23: 313-324.
40. Bakshi A, Shimizu S, Keck CA, Cho S, LeBold DG, et al. (2006) Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci 23: 2119-2134.
41. Makar TK, Bever CT, Singh IS, Royal W, Sahu SN, et al. (2009) Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 210: 40-51.
42. Winn SR, Lindner MD, Lee A, Haggett G, Francis JM, et al. (1996) Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences. Exp Neurol 140: 126-138.
43. Zimmermann H, Shirley SG, Zimmermann U, (2007) Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep 7: 314-320.
44. Murua A, Portero A, Orive G, Hernandez RM, de Castro M, et al. (2008) Cell microencapsulation technology: towards clinical application. J Control Release 132: 76-83.
45. Thanos CG, Emerich DF, (2008) On the use of hydrogels in cell encapsulation and tissue engineering system. Recent Pat Drug Deliv Formul 2: 19-24.
46. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, et al. (2007) Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 14: 157-161.
47. Skinner SJ, Geaney MS, Lin H, Muzina M, Anal AK, et al. (2009) Encapsulated living choroid plexus cells: potential long-term treatments for central nervous system disease and trauma. J Neural Eng 6: 065001.
48. Coleman B, Hardman J, Coco A, Epp S, de Silva M, et al. (2006) Fate of embryonic stem cells transplanted into the deafened mammalian cochlea. Cell Transplantation 15: 369-380.
49. Brigadski T, Hartmann M, Lessmann V, (2005) Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins. J Neurosci 25: 7601-7614.
50. Hartmann M, Heumann R, Lessmann V, (2001) Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20: 5887-5897.
51. Haubensak W, Narz F, Heumann R, Lessmann V, (1998) BDNF-GFP containing secretory granules are localized in the vicinity of synaptic junctions of cultured cortical neurons. J Cell Sci 111 (Pt 11): 1483-1493.
52. Brockes JP, Fields KL, Raff MC, (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165: 105-118.
53. Gillespie LN, Shepherd RK, (2005) Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci 22: 2123-2133.
54. Chen Z, Kujawa SG, McKenna MJ, Fiering JO, Mescher MJ, et al. (2005) Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release 110: 1-19.
55. Fiering J, Mescher MJ, Leary Swan EE, Holmboe ME, Murphy BA, et al. (2009) Local drug delivery with a self-contained, programmable, microfluidic system. Biomed Microdevices 11: 571-578.
56. Richardson RT, Wise AK, Andrew JK, O'Leary SJ, (2008) Novel drug delivery systems for inner ear protection and regeneration after hearing loss. Expert Opin Drug Deliv 5: 1059-1076.
57. Saijo S, Kimura RS, (1984) Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 97: 593-610.
58. Salt AN, Ma Y, (2001) Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 154: 88-97.
59. Cureoglu S, Schachern PA, Rinaldo A, Tsuprun V, Ferlito A, et al. (2005) Round window membrane and labyrinthine pathological changes: an overview. Acta Otolaryngol 125: 9-15.
60. McAllister AK, Katz LC, Lo DC, (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22: 295-318.
61. Thoenen H, Sendtner M, (2002) Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci 5 (Suppl): 1046-1050.
62. Lalwani AK, Han JJ, Walsh BJ, Zolotukhin S, Muzyczka N, et al. (1997) Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 114: 139-147.
63. Stover T, Yagi M, Raphael Y, (2000) Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 7: 377-383.
64. Salt AN, (2010) Cochlear fluids volumes for the guinea pig. http://oto2.wustl.edu/cochlea/mrgpvol. Accessed: 22nd March, 2011.
65. Salt AN, (2010) Cochlear fluids volumes for the human. http://oto2.wustl.edu/cochlea/mrhmvol. Accessed: 22nd March, 2011.